Ab initio studies of some amino acid residue complexes with 4-mercaptopyridine as a model for Thymitaq (AG337), an inhibitor of thymidylate synthase Journal Article


Authors: Sapse, D. S.; Tong, Y.; Bertino, J. R.; Sapse, A. M.
Article Title: Ab initio studies of some amino acid residue complexes with 4-mercaptopyridine as a model for Thymitaq (AG337), an inhibitor of thymidylate synthase
Abstract: The complex formed by isopentane, as a model for the isoleucine residue present in the wild-type thymidylate synthase, with 4-mercaptopyridine as a fragment of the thymidylate synthase inhibitor Thymitaq (AG337) is investigated with ab initio quantum chemical calculations at Hartree-Fock and MP2 levels, using the 3-21G* basis set. The binding energy is compared with the binding energies of 4-mercaptopyridine with amino acid residues found in mutant thymidylate synthase enzymes. As compared with isoleucine, alanine and glycine do not show binding, in agreement with enzyme-inhibition results.
Keywords: human tissue; unclassified drug; human cell; pyridines; binding affinity; enzyme inhibition; amino acid substitution; protein binding; drug structure; cancer inhibition; geometry; thermodynamics; isoleucine; binding sites; alanine; amino acids; thymidylate synthase inhibitor; thymidylate synthase; structure analysis; quinazolines; electrons; models, chemical; glycine; amino acid analysis; hydrogen; raltitrexed; quantum chemistry; nolatrexed; ions; benzene; acetamides; human; priority journal; article; methane; 4 mercaptopyridine; isopentane; metesind glucuronate; pentanes
Journal Title: Cancer Investigation
Volume: 17
Issue: 6
ISSN: 0735-7907
Publisher: Informa Healthcare  
Date Published: 1999-01-01
Start Page: 396
End Page: 401
Language: English
PUBMED: 10434950
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 16 August 2016 -- Source: Scopus
Citation Impact
MSK Authors
  1. Joseph Bertino
    363 Bertino